APOE and Alzheimer disease: Researchers have found that CRISPR/Cas9 has a very high accuracy rate in correcting disease-causing genes, and it has been found that converting APOE4 to APOE3 in iPSCs carrying the APOE4 allele greatly reduces the AD-related properties of the cells (Liu et al., 2024).